Phospho-Caspase-2 (S157) Polyclonal Antibody, 50ul Multiplex Immunoassays A mutation in this gene

A mutation in this gene is associated with autosomal dominant cerebral ataxia

secretory carrier membrane protein 4 (Gene ID: 113178)

Antagonists of this receptor have a potential therapeutic use in inhibiting tumor cell growth

an endogenous ligand for both corticotropin-releasing factor receptor 1 and corticotropin-releasing factor receptor 2

Phospho-Caspase-2 (S157) Polyclonal Antibody, 50ul Multiplex Immunoassays A mutation in this geneCASP2 (caspase 2) encodes a member of the cysteine aspartic acid protease (caspase) family. Caspases mediate cellular apoptosis through the proteolytic cleavage of specific protein substrates. The encoded protein may function in stress induced cell death pathways, cell cycle maintenance, and the suppression of tumorigenesis. Increased expression of CASP2 may play a role in neurodegenerative disorders including Alzheimer's disease, Huntington's disease